|
IM-L 20-001_000
|
Photanol
|
Productie van organisch zuur met cyanobacteriën
|
|
Ontwerpbesluit genomen
|
|
IM-MV 19-002_004
|
Universitair Medisch Centrum Utrecht
|
Clinical testing of JNJ-68284528, composed of autologous T cells genetically modified with a lentiviral vector (LVV) to express a chimeric antigen receptor (CAR) that, upon reinfusion into the patient, recognize and kill B-cell maturation antigen (BCMA)-expressing tumour cells
|
22-03-2021
|
Vergunning verleend
|
|
IM-MV 19-011_004
|
Erasmus MC
|
Clinical testing of JNJ-68284528, composed of autologous T cells genetically modified with a lentiviral vector (LVV) to express a chimeric antigen receptor (CAR) that, upon reinfusion into the patient, recognize and kill B-cell maturation antigen (BCMA)-expressing tumour cells
|
22-03-2021
|
Vergunning verleend
|
|
IM-MV 19-014_004
|
UMCG
|
Clinical testing of JNJ-68284528, composed of autologous T cells genetically modified with a lentiviral vector (LVV) to express a chimeric antigen receptor (CAR) that, upon reinfusion into the patient, recognize and kill B-cell maturation antigen (BCMA)-expressing tumour cells
|
22-03-2021
|
Vergunning verleend
|
|
IM-MV 20-015_000
|
AMC
|
A Clinical Study to Evaluate the Safety, Reactogenicity, Immunogenicity and Efficacy of an Ad26 and/or MVA-BN clinical vector for the prevention or treatment of infectious diseases
|
01-04-2021
|
Vergunning verleend
|
|
IM-MV 20-018_000
|
LUMC
|
Exposure of human test subjects to live genetically attenuated PfDmei2 (LA-GAP) malaria parasites
|
04-02-2021
|
Vergunning verleend
|
|
IM-MV 20-019_000
|
Stichting Katholieke Universiteit
|
Exposure of human test subjects to live genetically attenuated PfDmei2 (LA-GAP) malaria parasites
|
08-02-2021
|
Vergunning verleend
|
|
IM-MV 20-020_000
|
Intervet International
|
Ontwikkeling van een levend vaccin tegen Histophilus luchtweginfecties in kalveren
|
16-03-2021
|
Vergunning verleend
|
|
IM-MV 21-002_000
|
Intervet International
|
Vaccinatie van kippen met een recombinant herpes virus of turkey met een of meerdere inserties van het F gen van Newcastle disease virus, het VP2 gen van Infectious bursal disease virus en/of de glycoproteïnes I en D van Infectious laryngotracheitis virus
|
|
Ontwerpbesluit genomen
|
